Dark

QNCX
Quince Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Apr 10, 2026 3:59:54 PM EDT

0.1300USD+8.731%(+0.0108)117,367,498

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Apr 10, 2026 9:28:30 AM EDT

0.1111USD-10.186%(-0.0126)2,714,998

After-hours

Apr 10, 2026 4:57:30 PM EDT

0.1220USD-9.294%(-0.0120)1,151,540

OverviewOptionsHistoricalExchangesShortsTrends

open chart

Market Cap

7.51M

Industry

Biotechnology

Next Earnings

May 12, 2026 (31d)

QNCX Stats

Avg. Vol. 10 Day

224,651,059

Avg. Vol. 30 Day

96,451,962

Employees

Market Cap

7,511,433

Shares Out.

55,681,490

On/Off Exchange

44%/56%

6 Month Beta

2.60

1 Year Beta

1.35

2 Year Beta

0.32

3 Year Beta

0.26

52 Week Low

0.08

52 Week High

4.55

SMA50

0.15

SMA200

1.68

1 Week

+54.17%

1 Month

+24.22%

3 Month

-95.43%

6 Month

-92.79%

1 Year

-86.51%

2 Year

-86.51%

5 Year

-92.94%

Profile

cortexyme is developing therapeutics based on data supporting a new theory of the cause of alzheimer's and other degenerative disorders. cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration and beta amyloid production. the target has been validated in a number of animal models and cortexyme is currently moving a proprietary small molecule towards human clinical testing.

QNCX Stock Summary

Quince Therapeutics, Inc. Common Stock (NASDAQ:QNCX) stock price today is $0.1300, and today's volume is 117,367,498. QNCX is up 8.731% today. The 30 day average volume is 96,451,962. QNCX market cap is 7.51M with 55,681,490 shares outstanding.

.dark-mode .SFMFzg{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .SFMFzg{ color: #333333; background-color: white; border: 2px solid #333333; }QNCXQuince Therapeutics, Inc. Common Stockstock NASDAQ

QNCX Stock Summary

QNCX
Quince Therapeutics, Inc. Common Stock
stock NASDAQ